Climb Bio CLYM
NASDAQ CLYM
$10.94 -0.13 (-1.17%)
At close: Oct 2, 2026 · 4:00 PM EDT

Climb Bio (CLYM) Property, Plant & Equipment (Net) (2024 - 2026)

Updated

Climb Bio's Property, Plant & Equipment (Net) was $695,000 in Q2 2026, up 121.3% from $314,000 a year earlier and up 178.0% from the prior quarter.

Analysis

Climb Bio (CLYM) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

At the end of FY2025, Property, Plant & Equipment (Net) at Climb Bio came in at $288,000, up 44.7% from FY2024.

  • In earlier years, Property, Plant & Equipment (Net) was $199,000 in FY2024.
  • Per Business Quant data, CLYM's Property, Plant & Equipment (Net) in the three quarters before Q2 2026 was $250,000 (Q1 2026), $288,000 (Q4 2025) and $318,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Climb Bio 833.13 Mn 833.13 Mn - 695,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 695,000.00
Mar 31, 2026 250,000.00
Dec 31, 2025 288,000.00
Sep 30, 2025 318,000.00
Jun 30, 2025 314,000.00
Dec 31, 2024 199,000.00
API Access

Climb Bio Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=CLYM&period=max&api_key=YOUR_API_KEY